We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
PLXP

Price
-
Stock movement down
-0.00 (-4.76%)
Company name
PLx Pharma Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Pharmaceuticals
Market cap
116.55K
Ent value
-18.69M
Price/Sales
0.03
Price/Book
0.00
Div yield
-
Div growth
-
Growth years
-
FCF payout
-4.26%
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-36.39%
1 year return
-99.79%
3 year return
-89.34%
5 year return
-75.30%
10 year return
-
Last updated: 2024-12-17

DIVIDENDS

PLXP does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales0.03
Price to Book0.00
EV to Sales-4.11

FINANCIALS

Per share

Loading...
Per share data
Current share count29.14M
EPS (TTM)-0.96
FCF per share (TTM)-2.07

Income statement

Loading...
Income statement data
Revenue (TTM)4.54M
Gross profit (TTM)202.64K
Operating income (TTM)-64.42M
Net income (TTM)-27.58M
EPS (TTM)-0.96
EPS (1y forward)-1.10

Margins

Loading...
Margins data
Gross margin (TTM)4.46%
Operating margin (TTM)-1417.83%
Profit margin (TTM)-606.92%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash25.83M
Net receivables139.00K
Total current assets30.22M
Goodwill2.06M
Intangible assets0.00
Property, plant and equipment0.00
Total assets33.22M
Accounts payable5.07M
Short/Current long term debt0.00
Total current liabilities6.31M
Total liabilities7.02M
Shareholder's equity26.20M
Net tangible assets8.13M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-59.34M
Capital expenditures (TTM)0.00
Free cash flow (TTM)-59.34M
Dividends paid (TTM)2.52M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-105.25%
Return on Assets-83.01%
Return on Invested Capital-105.25%
Cash Return on Invested Capital-226.46%

STOCK INFORMATION

Downside potential

Loading...
Downside potential data
PLXPS&P500
Current price drop from All-time high-100.00%-8.48%
Highest price drop-100.00%-56.47%
Date of highest drop6 Jun 20239 Mar 2009
Avg drop from high-75.65%-11.07%
Avg time to new high194 days12 days
Max time to new high1985 days1805 days
COMPANY DETAILS
PLXP (PLx Pharma Inc) company logo
Marketcap
116.55K
Marketcap category
Small-cap
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey. On April 13, 2023, PLx Pharma Inc. along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Employees
16
Investor relations
-
SEC filings
CEO
Natasha Giordano
Country
USA
City
Sparta
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner